Further pharmacodynamic experiments in potassium oxonate–hypoxanthine-induced hyperuricemia rats revealed the hypouricemic effects of the PLR-CDs, and the hypouricemic efficacy was exerted primarily through inhibition of xanthine oxidase activity. This evidence concerns the gene XDH and hyperuricemia.